News und Analysen
2 Stocks Under $15 to Consider Buying
Some investors might be tempted to disregard stocks with low price tags. However, that could be a mistake. While it is true that price sometimes reflects quality, other times, it is possible to find
What Is TRACE and How Can It Help Me?
When securities are listed on a centralized exchange, such as the New York Stock Exchange or Nasdaq, transaction information such as price and trade history is readily available to investors through
Why Bitcoin, Ethereum, and Dogecoin Rallied Today
The prices of several major cryptocurrencies jumped on Tuesday amid increased speculation over the imminent approval of the first spot Bitcoin (CRYPTO: BTC) exchange-traded fund (ETF) by the U.S
The 3 Safest Warren Buffett Stocks to Buy and Hold for the Next 20 Years
Warren Buffett isn't a riverboat gambler. The legendary investor didn't amass a fortune of over $113 billion by taking ill-advised risks.
It makes sense, therefore, that many of the stocks in
3 Superior Stocks That Billionaires Can't Stop Buying
Following the stock picks of the world's wealthiest investors can work to your advantage. Just about all of them use a value approach to stock selection like Warren Buffett. When billionaire
Why Bitcoin and Other Major Cryptocurrencies Rallied This Week
Major cryptocurrencies have soared over the past week, led by a 9% rise in the price of Bitcoin (CRYPTO: BTC). As of Friday's close, Bitcoin SV (CRYPTO: BSV) -- a bitcoin fork token -- was up 61.6%
History Says the S&P 500 Is Soaring Toward a Record High: 2 Magnificent Growth Stocks Near a 52-Week Low to Buy Now
Global equities markets fell sharply last year as macroeconomic headwinds hammered economies around the world. The S&P 500 -- a diversified index that covers more than half of global equities by
Why Cannabis Stocks Like Canopy Growth and Cresco Labs Plummeted Today
Investors were hardly getting a buzz from marijuana stocks on Wednesday. Many titles in the sector were hit with sell-offs, including but by no means limited to Canopy Growth (NASDAQ: CGC), with its
This Top Marijuana Stock Is Making a Big Move to a Major Exchange
Major stock exchanges have, for the most part, taken tough stances on marijuana companies operating in the U.S. Up until recently, you wouldn't have found a multi-state operator (MSO) trading on a
Where Will Cresco Labs Be in 3 Years?
During the last three years, shares of Cresco Labs (OTC: CRLBF) lost 76% of their value. Shareholders are doubtlessly hoping that the next three years will be a lot better.
Is that a realistic
False Alarm: Misreported ETF Approval Sends Bitcoin, Related Stocks on a Wild Ride
Bitcoin (CRYPTO: BTC) and related stocks soared on Monday morning. The largest cryptocurrency gained as much as 8.4%, according to data from S&P Global Market Intelligence. Grayscale Bitcoin Trust
Here's Why Investors Should Buy Formula 1 Stock -- With or Without Apple
The Formula 1 (F1) championship has delivered some of the most thrilling racing action in the world for 73 years, and the sport is currently bigger than ever going by fan attendance and financial
2 No-Brainer Growth Stocks to Buy With $300 in October
We know $300 isn't a king's ransom, but it could help set the stage for epic returns in the stock market if invested in the right companies over a long-enough time frame. And while most investors
Why Orchard Therapeutics Stock Is Soaring Today
Shares of the commercial-stage gene therapy company Orchard Therapeutics (NASDAQ: ORTX) were up by a noteworthy 98% on sky-high volume as of 10:13 a.m. ET Thursday morning. The biotech's stock is
1 Growth Stock Down 50% to Buy Hand Over Fist
In this video, I will talk about Adyen (OTC: ADYY.F), why the stock is down 50% since the company reported earnings in August, and why I believe it is looking very attractive for long-term
1 Top Semiconductor Stock That's Too Cheap to Ignore
2022 and 2023 haven't been great years for most of the semiconductor industry. PC and smartphone sales fell off a cliff after elevated pandemic-era consumer purchasing, and later in 2023, this was
Why Aurora Cannabis and Canopy Growth Popped Today, but Cresco Labs Dropped
Marijuana stocks were trending in different directions Tuesday morning. Cresco Labs (OTC: CRLBF) shares shed 6.7% through 10:37 a.m. ET, while rival Aurora Cannabis (NASDAQ: ACB) gained 6.5%. And
Got $500? 1 Top Growth Stock to Buy Hand Over Fist in September.
You might remember Luckin Coffee (OTC: LKNC.Y) for all the wrong reasons. In 2019, its former management fabricated $300 million worth of sales, leading to Chapter 15 bankruptcy and delisting from
Why Canopy Growth, Aurora Cannabis, and Cresco Labs Stocks Fell on Monday
Marijuana stocks started out the new week on a down note Monday, with shares of Aurora Cannabis (NASDAQ: ACB) slipping 6%, Cresco Labs (OTC: CRLBF) sliding 6.2%, and Canopy Growth (NASDAQ: CGC) down
Why Canopy Growth, Aurora Cannabis, Cresco Labs, and Curaleaf Stocks All Popped
It's finally Friday, and it's looking like marijuana stocks are going to end this week on another high note.
Thanks to a couple of optimistic price targets just released by Wall Street bankers
This Cannabis Company Is Buying Back $50 Million Worth of Its Shares: Here's Why That Matters
Cash burn, reverse stock splits, and consistent losses are three things investors have come to expect from cannabis companies. And lately, there's also been a lack of growth. But there is one
This $50 Billion Artificial Intelligence (AI) IPO Is Generating Massive Interest. There's Also a Huge Red Flag
After back-to-back record-setting performances in 2020 and 2021, the market for initial public offerings (IPOs) hit a slump. The general market downturn last year caused many companies to delay
Why Canopy Growth, Aurora Cannabis, and Cresco Labs Stocks Sank Today
Pop!
Might that great sucking sound, that we just heard, the noise of the marijuana stock bubble finally popping? After two full weeks of incredible gains, shares of two of the best known pot
Why T-Mobile Stock Could Break $150 This Year
T-Mobile (NASDAQ: TMUS) stock has consistently butted heads with a $150 share price, but that could change soon.
There's a good reason T-Mobile shares are stuck below $150. As part of its merger
Does Nestlé's Biotech Segment Make It a Buy?
Biotech is probably not the first, second, or third thing that comes to mind when you think of Nestlé, (OTC: NSRGY) the Swiss packaged foods juggernaut responsible for a smorgasbord of delectable